Valerie Ohlendorf
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Cirrhosis-associated immune dysfunction (CAID)
Journal: Deutsche medizinische Wochenschrift (1946)
Published: February 09, 2026
Particularly strong immune response to influenza vaccination in patients with decompensated liver cirrhosis linked to systemic inflammation.
Journal: Frontiers in immunology
Published: October 28, 2025
Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure - Data from the German Hepatitis C-Registry (DHC-R).
Journal: Zeitschrift fur Gastroenterologie
Published: May 13, 2025
Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 30, 2024
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis.
Journal: Clinical and molecular hepatology
Published: July 22, 2024
Limited stability of Hepatitis B virus RNA in plasma and serum.
Journal: Scientific reports
Published: March 16, 2024
Limited Value of HBV-RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative Hepatitis B Patients.
Journal: Journal of viral hepatitis
Published: March 05, 2024
Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment.
Journal: Viruses
Published: December 11, 2023
Reply to the letter "Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B".
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 09, 2023
Low anti-HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen-negative patients.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 20, 2022
Glecaprevir/Pibrentasvir + Sofosbuvir + Ribavirin as a salvage regimen after Sofosbuvir + Velpatasvir + Voxilaprevir re-treatment failure
Journal: Zeitschrift fur Gastroenterologie
Published: October 19, 2021
Last Updated: 09/26/2026